The cells in our body also possess a lifecycle. They get damaged, they repair themselves, and if the intensity of the damage is too severe, they end up dying. But if these damaged cells stay in your body for a longer time, then they can affect your tissues by releasing some inflammatory substances. Senolytics are one of the emerging discoveries in medicine that can remove these senescent cells to protect your body from the potential threat of cancer.
Senescent cells and senolytics
Senescent cells are old or damaged cells that keep revolving in your body but do not die. Instead, they remain in your body and release some inflammatory substances that can damage your healthy tissues. These damaged cells may naturally increase your stress and anxiety as you age. Senolytics are designed exactly to eliminate such senescent cells and prevent you from the risk of cancer.
How can senescent cells lead to cancer?
Although senescent cells don’t divide, they release inflammatory molecules into their surroundings. These substances can create an environment that can give rise to chronic inflammation. These inflammatory substances can allow these cells to grow and survive in your body. All of this can eventually lead to the gradual development of cancer.
Can senolytic drugs prevent cancer?
Senescent cells can create an environment for cancer cells to grow, and senolytic drugs are designed to destroy this exact environment. A study published by Cancer Research UK in June 2023 explains this even further. Destroying senescent cells can lower the rates of inflammation and give rise to a healthier environment, which can prevent cancer.
What does research say about this?
Researchers are currently seeing senolytic drugs being added to cancer treatment. A study published by the National Library of Medicine in December 2024 states that senolytics are enhancing existing anti-tumor therapies. Another study by Drug Target Review in May 2025 talks about how senolytics can enhance immunotherapy when combined. While these therapies are offering new promises, they still need further investigation before being standardized.
Challenges and future
Senolytics might show a promising future, but there are some challenges that still remain. Researchers are still configuring the way that this drug ensures safety and removes only senescent cells without harming other tissues. Most of these tests are conducted in labs with less human data available. Also, scientists are still determining the way to benefit most patients and when the treatment should be given.
A promising solution
While senolytics are still under study, they have given new hope for a better future. With the ongoing research and emerging therapies, it is confirmed that senolytics can prevent cancer. If this continues similarly, then maybe one day, treating cancer can be more effective than it is today.